Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Virology|August 27, 2014
Analysis of JC virus DNA replication using a quantitative and high-throughput assayJong Shin, Paul J Phelan, Panharith Chhum, et al.
The Oncologist|January 9, 2026
DNA And RNA-Based Next-Generation Sequencing For Companion Diagnostic Rearrangement Detection In Solid TumorsRachel B Keller-Evans, Jessica K Lee, Justin M Allen, et al.
JCO Precision Oncology|January 20, 2022
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal AdenocarcinomaLiangliang Zhang, Omar Hamdani, Ole Gjoerup, et al.
JCO Precision Oncology|September 3, 2021
Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment PatternsJessica K Lee, Russell Madison, Anthony Classon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNAJessica K Lee, Mehlika Hazar-Rethinam, Brennan Decker, et al.
Cancer Medicine|January 15, 2026
Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic ImplicationsDouglas I Lin, Elizabeth Lawrence, Natalie Danziger, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
The Oncologist|June 3, 2021
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsMason A Israel, Natalie Danziger, Kimberly A McGregor, et al.
JCO Precision Oncology|May 14, 2026
Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling PlatformsDean C Pavlick, Shruthi Rengarajan, Jessica K Lee, et al.
JCO Precision Oncology|October 20, 2022
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA SamplesHatim Husain, Dean C Pavlick, Bernard J Fendler, et al.
Pageof 4